These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 26815016)

  • 21. Regulation of anti-cyclic citrullinated peptide antibodies in rheumatoid arthritis: contrasting effects of HLA-DR3 and the shared epitope alleles.
    Irigoyen P; Lee AT; Wener MH; Li W; Kern M; Batliwalla F; Lum RF; Massarotti E; Weisman M; Bombardier C; Remmers EF; Kastner DL; Seldin MF; Criswell LA; Gregersen PK
    Arthritis Rheum; 2005 Dec; 52(12):3813-8. PubMed ID: 16320316
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anti-citrullinated protein antibody positive rheumatoid arthritis is primarily determined by rheumatoid factor titre and the shared epitope rather than smoking per se.
    Murphy D; Mattey D; Hutchinson D
    PLoS One; 2017; 12(7):e0180655. PubMed ID: 28708862
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of BACH2 and RAD51B as rheumatoid arthritis susceptibility loci in a meta-analysis of genome-wide data.
    McAllister K; Yarwood A; Bowes J; Orozco G; Viatte S; Diogo D; Hocking LJ; Steer S; Wordsworth P; Wilson AG; Morgan AW; ; ; Kremer JM; Pappas D; Gregersen P; Klareskog L; Plenge R; Barton A; Greenberg J; Worthington J; Eyre S
    Arthritis Rheum; 2013 Dec; 65(12):3058-62. PubMed ID: 24022229
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HLA-DPB1-COL11A2 and three additional xMHC loci are independently associated with RA in a UK cohort.
    Orozco G; Barton A; Eyre S; Ding B; Worthington J; Ke X; Thomson W
    Genes Immun; 2011 Apr; 12(3):169-75. PubMed ID: 21293383
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Novel rheumatoid arthritis susceptibility locus at 22q12 identified in an extended UK genome-wide association study.
    Orozco G; Viatte S; Bowes J; Martin P; Wilson AG; Morgan AW; Steer S; Wordsworth P; Hocking LJ; ; ; ; Barton A; Worthington J; Eyre S
    Arthritis Rheumatol; 2014 Jan; 66(1):24-30. PubMed ID: 24449572
    [TBL] [Abstract][Full Text] [Related]  

  • 26. HLA-DRB1 genes, rheumatoid factor, and elevated C-reactive protein: independent risk factors of radiographic progression in early rheumatoid arthritis. Berlin Collaborating Rheumatological Study Group.
    Listing J; Rau R; Müller B; Alten R; Gromnica-Ihle E; Hagemann D; Zink A
    J Rheumatol; 2000 Sep; 27(9):2100-9. PubMed ID: 10990219
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of PTPN22 C1858T polymorphism on susceptibility and clinical characteristics of British Caucasian rheumatoid arthritis patients.
    Harrison P; Pointon JJ; Farrar C; Brown MA; Wordsworth BP
    Rheumatology (Oxford); 2006 Aug; 45(8):1009-11. PubMed ID: 16490755
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association between polymorphisms of interleukin 12 and rheumatoid arthritis associated biomarkers in a Chinese population.
    Shen L; Zhang H; Zhou X; Liu R
    Cytokine; 2015 Dec; 76(2):363-367. PubMed ID: 26375522
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Polymorphisms in STAT-4, IL-10, PSORS1C1, PTPN2 and MIR146A genes are associated differently with prognostic factors in Italian patients affected by rheumatoid arthritis.
    Ciccacci C; Conigliaro P; Perricone C; Rufini S; Triggianese P; Politi C; Novelli G; Perricone R; Borgiani P
    Clin Exp Immunol; 2016 Nov; 186(2):157-163. PubMed ID: 27342690
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association study of single nucleotide polymorphisms of IL23R and IL17 in rheumatoid arthritis in the Algerian population.
    Louahchi S; Allam I; Berkani L; Boucharef A; Abdesemed A; Khaldoun N; Nebbab A; Ladjouze A; Djidjik R
    Acta Reumatol Port; 2016; 41(2):151-7. PubMed ID: 27606475
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Associations between human leukocyte antigen, PTPN22, CTLA4 genotypes and rheumatoid arthritis phenotypes of autoantibody status, age at diagnosis and erosions in a large cohort study.
    Karlson EW; Chibnik LB; Cui J; Plenge RM; Glass RJ; Maher NE; Parker A; Roubenoff R; Izmailova E; Coblyn JS; Weinblatt ME; Shadick NA
    Ann Rheum Dis; 2008 Mar; 67(3):358-63. PubMed ID: 17666451
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A large-scale rheumatoid arthritis genetic study identifies association at chromosome 9q33.2.
    Chang M; Rowland CM; Garcia VE; Schrodi SJ; Catanese JJ; van der Helm-van Mil AH; Ardlie KG; Amos CI; Criswell LA; Kastner DL; Gregersen PK; Kurreeman FA; Toes RE; Huizinga TW; Seldin MF; Begovich AB
    PLoS Genet; 2008 Jun; 4(6):e1000107. PubMed ID: 18648537
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association of the PD-1.3A allele of the PDCD1 gene in patients with rheumatoid arthritis negative for rheumatoid factor and the shared epitope.
    Prokunina L; Padyukov L; Bennet A; de Faire U; Wiman B; Prince J; Alfredsson L; Klareskog L; Alarcón-Riquelme M
    Arthritis Rheum; 2004 Jun; 50(6):1770-3. PubMed ID: 15188352
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Progression of joint damage in early rheumatoid arthritis: association with HLA-DRB1, rheumatoid factor, and anti-citrullinated protein antibodies in relation to different treatment strategies.
    de Vries-Bouwstra JK; Goekoop-Ruiterman YP; Verpoort KN; Schreuder GM; Ewals JA; Terwiel JP; Ronday HK; Kerstens PJ; Toes RE; de Vries RR; Breedveld FC; Dijkmans BA; Huizinga TW; Allaart CF
    Arthritis Rheum; 2008 May; 58(5):1293-8. PubMed ID: 18438829
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Contribution of a haplotype in the HLA region to anti-cyclic citrullinated peptide antibody positivity in rheumatoid arthritis, independently of HLA-DRB1.
    Okada Y; Yamada R; Suzuki A; Kochi Y; Shimane K; Myouzen K; Kubo M; Nakamura Y; Yamamoto K
    Arthritis Rheum; 2009 Dec; 60(12):3582-90. PubMed ID: 19950296
    [TBL] [Abstract][Full Text] [Related]  

  • 36. HLA-DRB1 genotype influences risk for and severity of rheumatoid arthritis.
    Meyer JM; Evans TI; Small RE; Redford TW; Han J; Singh R; Moxley G
    J Rheumatol; 1999 May; 26(5):1024-34. PubMed ID: 10332964
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of HLA-DR-DR and DR-DQ associations in the expression of extraarticular manifestations and rheumatoid factor in rheumatoid arthritis.
    Perdriger A; Chalès G; Semana G; Guggenbuhl P; Meyer O; Quillivic F; Pawlotsky Y
    J Rheumatol; 1997 Jul; 24(7):1272-6. PubMed ID: 9228123
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The HLA-DRB1 shared epitope is not associated with antibodies against cyclic citrullinated peptide in Chinese patients with rheumatoid arthritis.
    Xue Y; Zhang J; Chen YM; Guan M; Zheng SG; Zou HJ
    Scand J Rheumatol; 2008; 37(3):183-7. PubMed ID: 18465452
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Particular association of clinical and genetic features with autoimmunity to citrullinated α-enolase in rheumatoid arthritis.
    Montes A; Dieguez-Gonzalez R; Perez-Pampin E; Calaza M; Mera-Varela A; Gomez-Reino JJ; Gonzalez A
    Arthritis Rheum; 2011 Mar; 63(3):654-61. PubMed ID: 21360494
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A new classification of HLA-DRB1 alleles differentiates predisposing and protective alleles for autoantibody production in rheumatoid arthritis.
    Gourraud PA; Dieudé P; Boyer JF; Nogueira L; Cambon-Thomsen A; Mazières B; Cornélis F; Serre G; Cantagrel A; Constantin A
    Arthritis Res Ther; 2007; 9(2):R27. PubMed ID: 17328818
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.